Medical device startup VytronUS raised $49 million in funding on Friday to help validate its imaging platform for the treatment of cardiac arrhythmias. Apple Tree Partners, New Enterprise Associates, BioStar Ventures and Windham Venture Partners participated in the Series C round. The Sunnyvale company has ra..."> Medical device startup VytronUS raised $49 million in funding on Friday to help validate its imaging platform for the treatment of cardiac arrhythmias. Apple Tree Partners, New Enterprise Associates, BioStar Ventures and Windham Venture Partners participated in the Series C round. The Sunnyvale company has ra..." /> Medical device startup VytronUS raised $49 million in funding on Friday to help validate its imaging platform for the treatment of cardiac arrhythmias. Apple Tree Partners, New Enterprise Associates, BioStar Ventures and Windham Venture Partners participated in the Series C round. The Sunnyvale company has ra..." />

Medical device maker VytronUS raises $49M to treat heart problems

< img src="http://media.bizj.us/view/img/10102417/john-pavlidis*100xx278-278-0-0.jpg" > Medical device startup VytronUS raised $49 million in funding on Friday to help validate its imaging platform for the treatment of cardiac arrhythmias. Apple Tree Partners, New Enterprise Associates, BioStar Ventures and Windham Venture Partners participated in the Series C round. The Sunnyvale company has raised $101 million to date. CEO John Pavlidis heads up the business, which was founded in 2006. The VytronUS system creates a high-resolutio n image of the interior of the heart. "We have developed… < div class="feedflare" > < a href="http://feeds.bizjournals.com/~ff/industry_6?a=72uFosU-_jA:2OxerCi-UFU:yIl2AUoC8zA" > < img src="http://feeds.feedburner.com/~ff/industry_6?d=yIl2AUoC8zA" border="0" > < /img > < /a > < /div >
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news